1. Home
  2. MPTI vs MDWD Comparison

MPTI vs MDWD Comparison

Compare MPTI & MDWD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo M-tron Industries Inc.

MPTI

M-tron Industries Inc.

HOLD

Current Price

$66.07

Market Cap

189.7M

Sector

N/A

ML Signal

HOLD

Logo MediWound Ltd.

MDWD

MediWound Ltd.

HOLD

Current Price

$17.81

Market Cap

224.6M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
MPTI
MDWD
Founded
1965
2000
Country
United States
Israel
Employees
N/A
N/A
Industry
Medicinal Chemicals and Botanical Products
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
189.7M
224.6M
IPO Year
N/A
2014

Fundamental Metrics

Financial Performance
Metric
MPTI
MDWD
Price
$66.07
$17.81
Analyst Decision
Strong Buy
Analyst Count
0
2
Target Price
N/A
$37.50
AVG Volume (30 Days)
32.3K
135.7K
Earning Date
02-25-2026
03-18-2026
Dividend Yield
N/A
N/A
EPS Growth
19.64
N/A
EPS
2.40
N/A
Revenue
$52,989,000.00
$20,932,000.00
Revenue This Year
$13.32
$6.97
Revenue Next Year
$10.56
$23.59
P/E Ratio
$26.77
N/A
Revenue Growth
12.79
6.15
52 Week Low
$34.50
$14.14
52 Week High
$67.52
$22.51

Technical Indicators

Market Signals
Indicator
MPTI
MDWD
Relative Strength Index (RSI) 60.25 46.81
Support Level $61.50 $17.10
Resistance Level $67.52 $18.48
Average True Range (ATR) 2.70 0.72
MACD -0.31 0.01
Stochastic Oscillator 62.51 52.43

Price Performance

Historical Comparison
MPTI
MDWD

About MPTI M-tron Industries Inc.

M-Tron Industries Inc is a diversified holding company with subsidiaries engaged in designing, manufacturing, and marketing high-engineered, high-reliability frequency and spectrum control products used to control the frequency or timing of signals in electronic circuits in various applications. The company's serving markets are aerospace and defense, space, and avionics. The company offers products such as microwave and millimeter wave filters; cavity, crystal, ceramic, lumped element, and switched filters; crystal resonators, integrated microwave assemblies, and solid-state power amplifier products.

About MDWD MediWound Ltd.

MediWound Ltd is an integrated biopharmaceutical company focused on developing, manufacturing, and commercializing novel therapeutic products to address unmet medical needs in the fields of severe burns, chronic and other hard-to-heal wounds, connective tissue disorders, and other indications. Its first biopharmaceutical product, NexoBrid is an FDA-approved orphan biologic for eschar removal in severe burns that can replace surgical interventions and minimize associated costs and complications. Its other product candidates in different stages of the pipeline include EscharEx for debridement of chronic wounds, and MW005 for the treatment of non-melanoma skin cancer. The company derives a majority of its revenue from the United States and the rest from the EU and other international markets.

Share on Social Networks: